亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

The Association Between COVID-19 Medications and AKI: Analysis of the United States Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) and Bulk Kidney RNA-seq Data

作者
Feng Cheng,Robert Morris,Rahinatu Ali,Jie Zhang,Jin Wei
出处
期刊:Journal of The American Society of Nephrology [American Society of Nephrology]
卷期号:34 (11S): 717-717
标识
DOI:10.1681/asn.20233411s1717a
摘要

Background: The FDA has approved three medications: Tocilizumab, Remdesivir, and Baricitinib, and issued several existing emergency use authorizations (EUAs) medications such as Paxlovid, REGEN_COV antibody et al., for the treatment of COVID-19. However, it has been observed that these medications may pose a risk factor for acute kidney injury (AKI). This study aims to investigate the potential association between the usage of these medications and the occurrence of AKI, as well as to elucidate the molecular mechanism underlying AKI induced by COVID-19 medications. Methods: The risk of AKI was compared among the COVID-19 patients receiving different medications. Pharmacovigilance data obtained from the FAERS was analyzed. Furthermore, we investigated whether the risk of AKI was influenced by factors such as sex, dosage, and potential drug-drug interactions among the medications used in COVID-19 patients. Additionally, we sought to identify genes and pathways associated with AKI that are regulated by COVID-19 medications, by comparing gene expression of kidneys from mice treated with COVID-19 medications to those from control mice. Whole kidney RNA-seq data was generated and analyzed. Results: We found that COVID-19 patients treated with remdesivir demonstrated a significantly higher risk of AKI compared to patients treated with other medications. Specifically, patients aged 50-70 or over 70 years were twice as likely to report AKI, compared to the <50 age demographic. Male patients prescribed remdesivir had a two-fold higher likelihood of reporting AKI compared to females. Additionally, patients who took vancomycin alongside remdesivir exhibited a 3.87-fold increased likelihood of reporting AKI as an adverse event (P<0.0001) when compared to patients prescribed vancomycin or remdesivir alone. Furthermore, RNA-seq revealed that genes up-regulated by remdesivir included Edar, Per1, Gadd45g, Wnt7b, Wnt16, Agt, and Dusp15. The corresponding regulated pathways include Stress-activated MAPK cascade and JNK cascade. Conclusions: COVID-19 patients treated with remdesivir exhibited a higher risk of reporting AKI as an adverse event than patients prescribed other approved treatments for COVID-19 infection. This increased occurrence of AKI may be attributed to the activation of MAPK/JNK signaling pathway. Funding: NIDDK Support, Private Foundation Support

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
深情安青的应助被小邹采纳,获得10
13秒前
1874发布了新的文献求助100
17秒前
受不了12345完成签到,获得积分10
17秒前
21秒前
petrichor发布了新的文献求助10
27秒前
27秒前
大猩猩发布了新的文献求助30
33秒前
之桃完成签到,获得积分10
37秒前
感性的鸡完成签到,获得积分10
38秒前
英俊鼠标完成签到 ,获得积分10
41秒前
41秒前
41秒前
41秒前
41秒前
1分钟前
xxrr发布了新的文献求助30
1分钟前
1分钟前
你奶奶发布了新的文献求助10
1分钟前
小二郎的应助被你奶奶采纳,获得10
1分钟前
1分钟前
从容美女发布了新的文献求助10
1分钟前
2分钟前
2分钟前
阿雷发布了新的文献求助10
2分钟前
ccc发布了新的文献求助10
2分钟前
粗心的烨伟完成签到,获得积分10
2分钟前
2分钟前
2分钟前
情怀的应助被科研通管家采纳,获得30
2分钟前
1874完成签到,获得积分10
2分钟前
和谐寻云完成签到,获得积分10
2分钟前
华仔的应助被ccc采纳,获得10
2分钟前
lyz完成签到,获得积分10
2分钟前
3分钟前
光亮静槐完成签到 ,获得积分10
3分钟前
小邹发布了新的文献求助10
3分钟前
3分钟前
申申完成签到 ,获得积分10
3分钟前
louis861933完成签到,获得积分10
3分钟前
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190113
求助须知:如何正确求助?哪些是违规求助? 9577216
关于积分的说明 21852162
捐赠科研通 7788317
什么是DOI,文献DOI怎么找? 3436259
关于科研通互助平台的介绍 2559990
邀请新用户注册赠送积分活动 2482862